AN INNOVATIVE PREP RESEARCH STUDY FOR WOMEN
HPTN 084 (LIFE) is a research study that compares the effectiveness of injections and oral tablets as pre-exposure prophylaxis (PrEP) to prevent HIV in women.
-
CABOTEGRAVIR FOR PREP
HPTN 084 (LIFE) is the first study to test if an injection of cabotegravir (CAB) given once every two months works better than a Truvada pill taken every day for HIV prevention in women. Truvada consists of the two anti-HIV drugs – emtricitabine and tenofovir disoproxil fumarate (TDF/FTC).